Loading fund…
Loading fund…
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | ▲ +0.2% | ▲ +1.9% | ▼ −0.8% | ▼ −1.5% | ▼ −1.5% | ▲ +22.3% | — | ▲ +16.3% |
| Peer average | ▲ +0.1% | ▲ +1.1% | ▼ −0.2% | ▼ −0.1% | ▲ +0.0% | ▲ +19.4% | ▲ +5.9% | — |
| S&P 500 · VOO | ▼ −0.4% | ▲ +0.9% | ▲ +3.3% | ▲ +13.8% | ▲ +13.3% | ▲ +88.8% | ▲ +81.9% | — |
iShares Trust - iShares iBonds Dec 2033 Term Corporate ETF is an exchange traded fund launched by BlackRock, Inc. The fund is managed by BlackRock Fund Advisors. It invests in the fixed income markets of global developed markets region. The fund invests in U.S. dollar-denominated, taxable, investment-grade securities publicly issued by U.S. and non-U.S. corporate issuers that are rated BBB- or higher by S&P or Fitch or Baa3 or higher by Moody’s. It invests in securities that will mature between January 1, 2033 and December 15, 2033. The fund seeks to track the performance of the Bloomberg U.S. Universal Index and the Bloomberg December 2033 Maturity Corporate Index, by using representative sampling technique. iShares Trust - iShares iBonds Dec 2033 Term Corporate ETF was formed on June 21, 2023 and is domiciled in the United States.
Distribution yield and SEC yield use different methodologies. Payouts may include income, capital gains, or return of capital.
| Ex-date | Pay date | Per share |
|---|---|---|
| 2026-11-02 | 2026-11-05 | $0.10 |
| 2026-10-01 | 2026-10-06 | $0.11 |
| 2026-09-01 | 2026-09-04 | $0.10 |
| 2026-08-03 | 2026-08-06 | $0.10 |
| 2026-07-01 | 2026-07-07 | $0.11 |
| 2026-06-01 | 2026-06-04 | $0.10 |
| 2026-05-01 | 2026-05-06 | $0.10 |
| 2026-04-01 | 2026-04-07 | $0.11 |
| 2026-03-02 | 2026-03-05 | $0.10 |
| 2026-02-02 | 2026-02-05 | $0.10 |
| 2025-12-19 | 2025-12-24 | $0.11 |
| 2025-12-01 | 2025-12-04 | $0.10 |
Estimated annual expense excludes trading costs and assumes constant assets. Fee waivers and fund costs can change.
Historical risk measures describe past behavior and do not predict future returns.
Hear the strategy from the people behind IBDY.